Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1

Conditions

Venous Thromboembolism 2Thrombosis 2Hemorrhage 2Venous Thrombosis 1Thromboembolism 1Thrombocytopenia 1Sarcoma 1Pulmonary Embolism 1Pancreatic Neoplasms 1Liver Neoplasms 1Hematoma 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1Bone Neoplasms 1

Interventions

anlotinib 1Tranexamic Acid 1Indocyanine Green 1Ifosfamide 1Hyperbaric Oxygenation 1Enoxaparin 1Doxorubicin 1Brachytherapy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Sarcoma × Enoxaparin × Clear all
NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation
2,868 enrolled
Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡